In vivo rodent erythrocyte micronucleus assay.

The following summary represents a consensus of the working group except where noted. The items discussed are listed in the order in which they appear in the OECD guideline (474) for easy reference. Introduction, purpose, scope, relevance, application and limits of test. The analysis of immature erythrocytes in either bone marrow or peripheral blood is equally acceptable for those species in which the spleen does not remove micronucleated erythrocytes. In the mouse, mature erythrocytes are also an acceptable cell population for micronucleus analysis when the exposure duration exceeds 4 weeks. Test substances. Organic solvents such as DMSO are not recommended. Freshly prepared solutions or suspensions should be used unless stability data demonstrate the acceptability of storage. Vegetable oils are acceptable as solvents or vehicles. Suspension of the test chemicals is acceptable for p.o. or i.p. administration but not for i.v. injection. The use of any unusual solvent should be justified. Selection of species. Any commonly used laboratory rodent species is acceptable. There is no strain preference. Number and sex. The size of experiment (i.e., number of cells per animal, number of animals per group) should be finalized based on statistical considerations. Although a consensus was not achieved, operationally it was agreed that 2000 cells per animal and four animals per group was a minimum requirement. In general, the available database suggests that the use of one gender is adequate for screening. However, if there is evidence indicating a significant difference in the toxicity between male and female, then both sexes should be used. Treatment schedule. No unique treatment schedule can be recommended. Results from extended dose regimens are acceptable as long as positive. For negative studies, toxicity should be demonstrated or the limit dose should be used, and dosing continued until sampling. Dose levels. At least three dose levels separated by a factor between 2 and square root of 10 should be used. The highest dose tested should be the maximum tolerated dose based on mortality, bone marrow cell toxicity, or clinical symptoms of toxicity. The limit dose is 2 g/kg/day for treatment periods of 14 days or less and 1 g/kg/day for treatment periods greater than 14 days. A single dose level (the limit dose) is acceptable if there is no evidence of toxicity. Controls. Concurrent solvent (vehicle) controls should be included at all sampling times. A pretreatment sample, however, may also be acceptable only in the short treatment period peripheral blood studies. A concurrent positive control group should be included for each experiment.(ABSTRACT TRUNCATED AT 400 WORDS)

[1]  M. Shelby,et al.  The in vivo erythrocyte micronucleus test: measurement at steady state increases assay efficiency and permits integration with toxicity studies. , 1990, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[2]  B. Ballantyne,et al.  In vitro and in vivo evaluation of the genotoxic potential of 2-ethyl-1,3-hexanediol. , 1988, Toxicology.

[3]  R. Balansky,et al.  Investigation of the mutagenic activity of tobacco smoke. , 1987, Mutation research.

[4]  M. Holmstrom.  Induction of micronuclei in bone marrow of mice exposed to 1, 2 or 3 daily doses of urethane. , 1990, Mutation research.

[5]  J. T. Macgregor,et al.  A simple fluorescent staining procedure for micronuclei and RNA in erythrocytes using Hoechst 33258 and pyronin Y. , 1983, Mutation research.

[6]  D. Jenssen,et al.  Genotoxicity testing of extracts of a Swedish moist oral snuff. , 1991, Mutation research.

[7]  M. Shelby,et al.  The induction of micronucleated polychromatic erythrocytes in mice using single and multiple treatments. , 1990, Mutation research.

[8]  B. Margolin,et al.  Guidelines for the conduct of micronucleus assays in mammalian bone marrow erythrocytes. , 1987, Mutation research.

[9]  V. Winters,et al.  Micronucleus induction by camptothecin and amsacrine in bone marrow of male and female CD-1 mice. , 1992, Mutagenesis.

[10]  T. Sofuni,et al.  Simulation study of the effects of multiple treatments in the mouse bone marrow micronucleus test. , 1991, Mutation research.

[11]  J. Ashby,et al.  Activity of aniline in the mouse bone marrow micronucleus assay. , 1991, Mutation research.

[12]  T. Kamei,et al.  Mutagenic evaluation of etintidine (BL-5641), a novel histamine H2-receptor antagonist, using the chromosome aberration test in CHL cells and the micronucleus test in mice. , 1987, Mutation research.

[13]  J. T. Macgregor,et al.  Non-clastogenicity in mouse bone marrow of fructose/lysine and other sugar/amino acid browning products with in vitro genotoxicity. , 1989, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[14]  Safety evaluation studies of SGF gum--a potential food additive from the seed of Sesbania cannabina. , 1988 .

[15]  S. Sutuo,et al.  Sex difference in the micronucleus test , 1985 .

[16]  B. Elliott,et al.  Inactivity of methylene chloride in the mouse bone marrow micronucleus assay. , 1987, Mutagenesis.

[17]  T. Pandita,et al.  Evaluation of Thimet 10-G for mutagenicity by 4 different genetic systems. , 1986, Mutation research.

[18]  J. C. Richardson.  A preliminary assessment of the cytogenetic effects of metepa on mouse bone marrow using the micronucleus test. , 1974, Mutation research.

[19]  G. P. Meshram,et al.  N,N-diethylphenylacetamide, an insect repellent: absence of mutagenic response in the in vitro Ames test and in vivo mouse micronucleus test. , 1988, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[20]  W. Blazak,et al.  Mutagenic and clastogenic properties of 3‐chloro‐4‐(dichloromethyl)‐5‐hydroxy‐2 (5H)‐furanone: A potent bacterial mutagen in drinking water , 1987, Environmental and molecular mutagenesis.

[21]  J. T. Macgregor,et al.  Clastogen-induced micronuclei in peripheral blood erythrocytes: the basis of an improved micronucleus test. , 1980, Environmental mutagenesis.

[22]  E. Loeser.  Long-term toxicity and carcinogenicity studies with 2,4/2,6-toluene-diisocyanate (80/20) in rats and mice. , 1983, Toxicology letters.

[23]  T. Sofuni,et al.  An application of Acridine Orange fluorescent staining to the micronucleus test. , 1983, Mutation research.

[24]  S. Lupo,et al.  Sex difference in sensitivity to the cytogenetic effects of ethyl methanesulfonate in mice demonstrated by the micronucleus test. , 1980, Mutation research.

[25]  D. Wild.  Cytogenetic effects in the mouse of 17 chemical mutagens and carcinogens evaluated by the micronucleus test. , 1978, Mutation research.

[26]  M. Kirsch‐Volders,et al.  Mouse micronucleus tests with known and suspect spindle poisons: results from two laboratories. , 1991, Mutagenesis.

[27]  H. Aeschbacher,et al.  Mutagen-sensitive strain of mice. , 1979, Mutation research.

[28]  I. Faengmark,et al.  Mutagenicity testing of condensates of smoke from titanium dioxide/hexachloroethane and zinc/hexachloroethane pyrotechnic mixtures. , 1991, Mutation research.

[29]  T. Sofuni,et al.  The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. , 1990, Mutation research.

[30]  Csgmt.  Micronucleus test with mouse peripheral blood erythrocytes by acridine orange supravital staining: the summary report of the 5th collaborative study by CSGMT/JEMS.MMS. The Collaborative Study Group for the Micronucleus Test. , 1992, Mutation research.

[31]  A. Wakata,et al.  Difference between intraperitoneal and oral gavage application in the micronucleus test. The 3rd collaborative study by CSGMT/JEMS.MMS. Collaborative Study Group for the Micronucleus Test/Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan. , 1989, Mutation research.

[32]  A. Deleener,et al.  Discrimination of aneuploidogens from clastogens by C-banding, DNA and area measurements of micronuclei from mouse bone marrow. , 1992, Mutation research.

[33]  Y. Paschin,et al.  Mutagenic effects of thiram in mammalian somatic cells. , 1985, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[34]  H. Aeschbacher,et al.  The effect of caffeine in the in vivo SCE and micronucleus mutagenicity tests. , 1986, Mutation research.

[35]  E. Longstaff,et al.  Activity of bromochlorodifluoromethane (BCF) in three mutation tests. , 1985, Mutation research.

[36]  I. Larripa,et al.  In vivo and in vitro cytogenetic effects of the anti-tumor agent amsacrina (AMSA). , 1984, Mutation research.

[37]  J Ashby,et al.  Inactivity of ethyl acrylate in the mouse bone marrow micronucleus assay. , 1989, Mutagenesis.

[38]  H. Renner,et al.  Mutagenic evaluation of single cell protein with various mammalian test systems. , 1978, Toxicology.

[39]  J. Ashby,et al.  N-chloropiperidine and calcium hypochlorite: possible examples of toxicity-dependent clastogenicity in vitro. , 1987, Mutation research.

[40]  J. Styles,et al.  Activity of vinyl chloride monomer in the mouse micronucleus assay. , 1983, Mutation research.

[41]  T. Sofuni,et al.  The micronucleus assay using peripheral blood reticulocytes from mitomycin C- and cyclophosphamide-treated rats. , 1992, Mutation research.

[42]  J. Ashby,et al.  Inactivity of glycerol formal in a mouse micronucleus assay: relationship to its teratogenicity. , 1986, Environmental mutagenesis.

[43]  P. Vanparys,et al.  Sampling times in micronucleus testing. , 1992, Mutation research.

[44]  B. Beek,et al.  Species differences in mutagenicity testing: I. Micronucleus and SCE tests in rats, mice, and Chinese hamsters with aflatoxin B1. , 1986, Teratogenesis, carcinogenesis, and mutagenesis.

[45]  I. Larripa,et al.  Mutagenic bioassay of certain pharmacological drugs. I. Thiabendazole (TBZ). , 1987, Mutation research.

[46]  T. Sofuni,et al.  High-sensitivity in micronucleus induction of a mouse strain (MS). , 1982, Mutation research.

[47]  A. Zijno,et al.  In vitro and in vivo mutagenicity studies with airborne particulate extracts. , 1988, Mutation research.

[48]  M C Cimino,et al.  The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency Gene-Tox Program. , 1990, Mutation research.

[49]  T. Sheldon.  An evaluation of caprolactam and benzoin in the mouse micronucleus test. , 1989, Mutation research.

[50]  V. Ramanujam,et al.  Micronucleus formation by benzene, cyclophosphamide, benzo(a)pyrene, and benzidine in male, female, pregnant female, and fetal mice. , 1989, Teratogenesis, carcinogenesis, and mutagenesis.

[51]  U. Kliesch,et al.  Sex differences in micronucleus induction with hycanthone methanesulfonate in bone marrow cells of mice. , 1992, Mutation research.

[52]  C L Chrisman,et al.  Micronuclei in bone-marrow cells of mice subjected to hyperthermia. , 1980, Mutation research.

[53]  C. Studygroupforthemicronucleus,et al.  Single versus multiple dosing in the micronucleus test: the summary of the fourth collaborative study by CSGMT/JEMS.MMS. Collaborative Study Group for the Micronucleus Test, the Mammalian Mutagenesis Study Group of the Environmental Mutagen Society, Japan (CSGMT/JEMS.MMS). , 1990, Mutation research.

[54]  D. Marzin,et al.  Study of mutagenic activity of troxerutin, a flavonoid derivative. , 1987, Toxicology letters.

[55]  M. Hite,et al.  Mutagenic evaluation of nitroparaffins in the Salmonella typhimurium/mammalian-microsome test and the micronucleus test. , 1979, Environmental mutagenesis.

[56]  U. Kliesch,et al.  Micronucleus test in bone marrow of mice treated with 1-nitropropane, 2-nitropropane and cisplatin. , 1987, Mutation research.

[57]  J. Meyne,et al.  Sex-related differences in cytogenetic effects of benzene in the bone marrow of Swiss mice. , 1980, Environmental mutagenesis.

[58]  R. Balansky,et al.  Clastogenic activity of urethane in mice. , 1992, Mutation research.

[59]  F Romagna,et al.  The automated bone marrow micronucleus test. , 1989, Mutation research.